Eli Lilly has reported a significant revenue increase of 47% in the second quarter, reaching $22.97 billion, despite a decline in employer insurance coverage for GLP-1 weight-loss medications from 72% to 60%. This situation raises questions about the sustainability of the weight…
The FDA has approved Eli Lilly's medication Mounjaro for reducing the risk of heart events in individuals with Type 2 diabetes. This approval adds to the drug's existing use for b…
New research indicates that individuals who consistently log their food intake may experience greater weight loss. An analysis of over 5,000 adults using a nutrition-tracking app…
A recent study suggests that intermittent fasting, a popular weight-loss strategy, may also influence chronic pain management by altering gut-brain communication. Researchers foun…
A recent study published in Cell Metabolism suggests that while ketogenic, Mediterranean, and low-fat diets can support weight loss, the ketogenic diet may provide additional bene…
A recent study published in Cell Metabolism compared the effects of three popular diets on metabolic health in individuals with obesity and prediabetes. The ketogenic diet demonst…
Researchers at the University of Utah have found that the gut bacterium Turicibacter may significantly reduce weight gain and improve metabolic health in mice, even when fed a hig…
A study published in Science Advances reveals that the experimental drug TOFA enables obese mice to lose fat without reducing their food intake or losing muscle mass. The compound…
As the popularity of weight-loss drugs like GLP-1 receptor agonists grows, a black market for the unapproved drug retatrutide has emerged, alarming health experts. Developed by El…
The ADAPT study protocol aims to explore the physiological mechanisms that contribute to weight loss plateaus in individuals undergoing behavioral weight loss. By monitoring parti…
A recent report from the National Restaurant Association highlights how GLP-1 weight-loss drugs are reshaping beverage choices in restaurants. As health consciousness rises, parti…
An inquest into the death of 73-year-old Caroline Savage revealed that doctors did not focus solely on her use of the weight-loss drug Mounjaro when assessing her symptoms. The co…
Sofia Carson has come under fire for her appearance at the LACMA Art+Film Gala, with fans expressing concern over Hollywood's extreme beauty standards. The backlash highlights a g…
NVIDIA and Eli Lilly have both reported impressive quarterly earnings, showcasing their respective growth potential. NVIDIA's revenue surged by over 105% year-over-year, driven by…
Novo Nordisk's stock fell by 7% after the company revealed its long-term growth strategy at a capital markets day, raising investor concerns about its ability to maintain its posi…
The Federal Reserve's latest Beige Book indicates a modest increase in US economic activity, slight employment growth, and moderate price increases. The report highlights mixed se…